The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Philip Ron M

Reporting owner CIK 0002063957 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Philip Ron MPhilip Ron MPhilip Ron M · October 15, 2026 · Stock award · Stock Option (Right to Buy)Philip Ron M · September 30, 2026 · Stock award · Stock Option (Right to Buy)Sep 30, 2026Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)Philip Ron MStock award
Sep 30, 2026Avalo Therapeutics, Inc.Stock Option (Right to Buy)Philip Ron MStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: CITY THERAPEUTICS, INC.CTY · company listings
Philip Ron MDirector
Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade: Avalo Therapeutics, Inc.AVTX · company listings
Philip Ron MDirector
Stock awardStock Option (Right to Buy)Derivative security · Code A1,10912.29 *Value: 13,629.61Currency not specifiedView ↗